Delivery Order SPE2DB24D1201-SPE2DB25FJDUG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract valued at $4,027.70, with an ultimate completion date of August 15, 2025. This non-competitive delivery order was issued on July 25, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. The award was made on July 30, 2025, with an ultimate completion date of August 20, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the delivery from its corporate office location. This delivery order represents a specific...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,027.70. This non-set-aside delivery order is scheduled for completion by August 18, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued against the vendor's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $3,676.12. The delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.12 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance conducted at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this contract action. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,083.10 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price contract. The award was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. This non-competitive delivery order does not utilize a set-aside designation and represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. Performance will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, for the supply of Ingrezza 60 mg capsules (30-count unit). The contract, valued at $4,049.61 with a firm fixed price structure, was awarded on August 4, 2025, with an ultimate completion date of August 25, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to meet federal procurement requirements in open competition....
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count) under a firm fixed price contract. The award was issued on July 24, 2025, with an ultimate completion date of August 14, 2025, and performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive, non-set-aside award and is characterized as a child contract,...
- The Defense Logistics Agency awarded a $3,676.12 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ingrezza 40 mg capsules (30-count units). The contract, which is not set-aside, carries a firm fixed price structure with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award represents a child contract under...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDUGDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3.68K. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99M through December 2026. The parent IDC functions as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military and federal healthcare systems globally. Through this contract vehicle, AmerisourceBergen serves multiple government customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a critical vendor within the federal medical supply chain. The DLA plans to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, potentially involving at least three contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/5/25 |